(607) 227-8695info@prendismo.com


Filter by :

Gender :

Race :

Age :

853 Videos
Sorted by Best match

Paul McManus Discusses Typs of Deals That Millenia

  • Invention To Venture - April 2006 - Paul
  • Paul E. McManus is the Director of Portfolio Company Executive Resources at Millennia Partners. P...
  • What we look at when we look at founders and core management teams, most life sciences, healthcare d...
  • 4/4/2006

Paul McManus Discusses Key Participants In Venture

  • Invention To Venture - April 2006 - Paul
  • Paul E. McManus is the Director of Portfolio Company Executive Resources at Millennia Partners. P...
  • Key areas for us of course, are in ... classically in therapeutics and medical devices area but like...
  • 4/4/2006

Paul McManus Provide Background of Millenia Partne

  • Invention To Venture - April 2006 - Paul
  • Paul E. McManus is the Director of Portfolio Company Executive Resources at Millennia Partners. P...
  • My job is very simply to help Boston Millenia as best as I can find the A players, the top team that...
  • 4/4/2006

Richard Ramko Shares Reasoning For Increasing Alli

  • Invention To Venture - April 2006 - Rich
  • Richard Ramko is a partner in Ernst & Young's South Florida practice, primarily serving publicly-...
  • I think we are seeing a lot more strategic alliances and partnering of early stage companies simply ...
  • 4/4/2006

Richard Ramko Shares Thoughts On Biotech Firms Cho

  • Invention To Venture - April 2006 - Rich
  • Richard Ramko is a partner in Ernst & Young's South Florida practice, primarily serving publicly-...
  • Well, I think going back to 2000 and such when there were a lot of companies that went public that p...
  • 4/4/2006

Richard Ramko States Product Approval In Biotech I

  • Invention To Venture - April 2006 - Rich
  • Richard Ramko is a partner in Ernst & Young's South Florida practice, primarily serving publicly-...
  • The resourcefulness of the industry is clearly evident in the number of product approvals and produc...
  • 4/4/2006

Richard Ramko States Losses In Biotech Sector Have

  • Invention To Venture - April 2006 - Rich
  • Richard Ramko is a partner in Ernst & Young's South Florida practice, primarily serving publicly-...
  • As can be seen above, the losses incurred by biotech companies have declined significantly since the...
  • 4/4/2006

Richard Ramko Discusses R&D Expenditures In Biotec

  • Invention To Venture - April 2006 - Rich
  • Richard Ramko is a partner in Ernst & Young's South Florida practice, primarily serving publicly-...
  • This table primarily, the reason we put this one in here is to show R&D expense or percentage of rev...
  • 4/4/2006

Laurie Halloran States Professional Role Is Helpin

  • Invention To Venture - April 2006 - Laur
  • Laurie Halloran is the President and Founder of Halloran Consulting Group. During her 18...
  • My job is basically working with people who think that clinical medicine is easily translated into c...
  • 4/4/2006